Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s ...

BIO strongly supports a manufacturer’s ability to use a 340B rebate as an appropriate option to make 340B pricing available to covered entities. "Manufacturers should have the choice to effectuate ...

WASHINGTON – BIO President & CEO John F. Crowley released the following statement on the results of the 2024 U.S. election: “We look forward to working closely with President-elect Trump, his incoming ...

Today, we explore BIO’s recommendations for how CMS can safeguard patient access under Medicare Part D, along with insights on a California Supreme Court case that could affect the complex drug ...

BIO filed an amicus brief in the Supreme Court of the State of California, encouraging its review of the lower court decision in the Gilead Tenofovir Cases. The Court of Appeal decision operates from ...

Rep. Hank Johnson discussed the impact of Georgia’s biosciences sector, and CPAC supports FTC action against PBMs. We have details, plus more news on bird flu, USDA biofuel grants, and more. Don’t ...

Jeff is a registered patent attorney and an intellectual property and innovation policy professional with a unique combination of training and real-world experience. Jeff has done policy work for ...

Kevin E. Noonan is co-Chair of MBHB’s Biotechnology and Pharmaceuticals Practice Group. Dr. Noonan is an experienced patent lawyer, molecular biologist and renowned thought leader in biotechnology and ...

9:00 AM - 9:10 AM (EDT), Tuesday, November 19, 2024 ...

October is the scariest time of year. Young goblins walk the streets demanding treats, local haunted houses are packed full of fright-chasing teens, and the airwaves are filled with gore-splattered ...

A special Friday edition with new data on 340B spending and a New York Times feature highlighting Pivot Bio's outstanding work to support farmers and the planet with biotech. (437 words, 2 minutes, 11 ...

A busy Monday brings all the highlights from BIO's Patient and Health Advocacy Summit last week, plus what BIO's talking about at the World Food Prize event in Iowa tomorrow. (793 words, 3 minutes, 57 ...